Tuesday, August 25, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
RegulatoryAbbVie Launches Phase 2 Forehead Lines StudyyesterdayMarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20303 days agoBusiness & M&AAllergan Aesthetics Overhauls Loyalty ProgramyesterdayDevices & TechXERF Technology Enters Australian Market for Skin Tightening3 days agoBusiness & M&AEvolus Expands Estyme to Canada, Australia, New ZealandyesterdayMarketArm Fat Now Top Body Sculpting Concern in Singapore3 days agoDevices & TechSofwave Hits One Million Treatments MilestoneyesterdayRegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted3 days agoRegulatoryRevance Wins FDA Nod for Under-Eye Injectables2 days agoMarketGLP-1 Pill Era Is Forcing Beauty Market Shift2 days agoInjectablesAEON Releases Expanded ABP-450 Botox Biosimilar Data2 days agoDevices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Lifting2 days ago
Brightening

Kojic Acid

Fungal-derived tyrosinase inhibitor that fades hyperpigmentation and dark spots.

Also known as: 5-hydroxy-2-hydroxymethyl-4H-pyran-4-one, kojic acid dipalmitate, Same name.

What it is
Kojic acid is a naturally occurring organic compound produced by certain fungi (notably Aspergillus and Acetobacter species) during fermentation. It's a small-molecule tyrosinase inhibitor that disrupts melanin synthesis at the enzyme level.
What it does
Kojic acid works by inhibiting tyrosinase, the enzyme responsible for converting the amino acid tyrosine into melanin. This reduces melanin production in melanocytes, leading to gradual fading of hyperpigmentation, age spots, melasma, and post-inflammatory hyperpigmentation. Results typically appear over 4–12 weeks of consistent use.
The evidence
Strong clinical evidence supports kojic acid's efficacy for melasma and post-inflammatory hyperpigmentation, with multiple controlled trials showing 20–40% improvement in pigmentation over 8–12 weeks. Moderate evidence exists for general brightening; it is less potent than hydroquinone but better tolerated.
Best for
Melasma, post-inflammatory hyperpigmentation, age spots, and uneven skin tone in all skin types, especially darker skin tones where irritation from stronger depigmenting agents is a concern.
Pairs well with
Niacinamide, vitamin C, glycolic acid, azelaic acid, and sunscreen (essential). Works synergistically with other tyrosinase inhibitors like arbutin or licorice extract.
Use cautiously with
Avoid combining with hydroquinone at high concentrations without professional guidance, as stacking depigmenting agents increases irritation risk. Use cautiously with strong exfoliants (retinoids, AHAs) in the same routine initially.
Cautions
Kojic acid can cause contact dermatitis and sensitization in 1–2% of users; patch test first. May increase photosensitivity slightly; daily SPF 30+ is mandatory. Generally safe in pregnancy, but consult a provider. Avoid if allergic to fungi or fermented products.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo